- Download 99
- File Size 1.27 MB
- File Count 1
- Create Date 1 August 2019
- Last Updated 1 October 2019
NEW IMI PROJECT “GNA NOW” KICKS OFF ITS BATTLE AGAINST ANTIMICROBIAL RESISTANCE
BIOASTER announces the kick off a new IMI project "GNA NOW" (Gram-Negative Antibacterials NOW), led by Evotec SE, managed by Lygature and funded by the Innovative Medicines Initiative (IMI), a public-private european R&D consortium.
The program will work on the development of novel antibacterial agents to battle antimicrobial resistance in gram-negative bacteria.
The multi-stakeholder consortium includes 9 other partners from academia, industry and SMEs: Nosopharm, BIOASTER, Helmholtz Centre for Infection Research, North Bristol National Health Service Trust, University of Liverpool, Inserm, Erasmus Medical Center, Medical University of Vienna, and Fraunhofer IME.